Guardant Health (GH) Liabilities and Shareholders Equity (2017 - 2026)

Guardant Health (GH) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $1.9 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 42.48% year-over-year to $1.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 billion (up 9.37% YoY) and the FY2025 annual result came in at $2.0 billion, up 35.54% from the prior year.
• Liabilities and Shareholders Equity eased to $1.9 billion in Q1 2026 per GH's latest filing, from $2.0 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $2.1 billion in Q1 2022, with the low at $1.3 billion in Q3 2025.
• Average Liabilities and Shareholders Equity over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2022.
• Year-over-year, Liabilities and Shareholders Equity retreated 29.02% in 2023 and jumped 42.48% in 2026.
• Guardant Health's Liabilities and Shareholders Equity stood at $1.6 billion in 2022, then climbed by 10.96% to $1.8 billion in 2023, then dropped by 16.84% to $1.5 billion in 2024, then jumped by 35.54% to $2.0 billion in 2025, then declined by 4.89% to $1.9 billion in 2026.
• Business Quant data shows GH's Liabilities and Shareholders Equity at $1.9 billion in Q1 2026, $2.0 billion in Q4 2025, and $1.3 billion in Q3 2025.